| About NicOx | |||
| Products | |||
| Naproxcinod NCX 6560 Full portfolio |
|||
| Maximizing portfolio | |||
| Co-development Research alliances Technology |
|||
| People | |||
| Board
of Directors Management Team Contacts Careers |
|||
| Investor & media | |||
| Press
releases Investor relations Fact file Financials Corporate governance "Informations Réglementées" Conferences |
|||
| Home | |||
| Directions
to NicOx Site en français |
|||
|
Information provided for under article 221-1 of the 'règlement général de l'AMF' |
||||
|
Information relating to the voting rights and number of shares |
||||
|
|
||||
|
Information relating to the description of share repurchase programs |
||||
|
|
||||